Piramal Pharma Solutions
Michael Linton possesses extensive experience in quality control and analytical testing within the pharmaceutical industry. Currently serving as a QC Commercial Team Leader at Piramal Pharma Solutions since July 2022, Michael previously held the position of Scientist 3 at Eurofins from September 2018 to November 2022, where responsibilities included performing GMP analysis according to client and in-house methods while utilizing data from the European Pharmacopeia and USP. Prior to that, Michael worked as an Analyst at Source BioScience and as a Lead Analyst at Charles River Laboratories, focusing on analytical testing of pharmaceutical final products under GMP/GLP standards for lot release and stability studies. Michael holds a Bachelor of Science degree in Forensic Science from Abertay University, completed in 2012.
This person is not in any offices
Piramal Pharma Solutions
3 followers
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide.